For:

  • Nanomaterials  
  • Advanced Materials
  • Chemical Substances and Preparations (REACH)
  • Cosmetic Ingredients

Includes:

  • Acute and Subacute Studies
    • Effect of a single dose on a particular animal species.
    • Duration: From several days to after a single dose.  
    • Parameters in acute studies: Mortality, Clinical pathology, Gross necropsy, Weight change, Signs of toxicity.
    • Parameters in sub-acute studies: Mortality, Weight change, Signs of toxicity, Clinical pathology, Pathology and histopathology
  • Subchronic & Chronic Studies
    • Establishing a “no observable effect level” (NOEL) and characterization of dose-response relationships following repeated doses.
    • Identification and determination of specific organs affected after repeated administration.
    • Prediction of a reasonable and appropriate dosing for chronic exposure studies. In case of chronic studies evaluation of the cumulative toxicity of chemicals and assessing a carcinogenic potential.
    • Duration: From 28 days, through 90 days up to 6 / 12 / 24 months.  
    • Parameters: Mortality, Weight change, Signs of toxicity, Clinical pathology, Pathology and histopathology.
  • Reproductive & Development Studies
    • Reproductive studies in vivo determines a potential adverse effects of a test item on fertility and reproductive performance / sexual function in adult males and females and as well as developmental toxicity in the offspring (UNECE).
    • Development (teratology) studies in vitro and in vivo pertains to adverse toxic effects to the developing embryo or foetus, resp. adverse effects induced during pregnancy.
    • Duration: Varies depending upon end point.  
    • Parameters: According to OECD and ECVAM Guidelines